{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:59:14Z","timestamp":1780541954231,"version":"3.54.1"},"reference-count":48,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Funds of China","award":["31570167"],"award-info":[{"award-number":["31570167"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Since emerging in 2012, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been a global public health threat with a high fatality rate and worldwide distribution. There are no approved vaccines or therapies for MERS until now. Passive immunotherapy with neutralizing monoclonal antibodies (mAbs) is an effective prophylactic and therapeutic reagent against emerging viruses. In this article, we review current advances in neutralizing mAbs against MERS-CoV. The receptor-binding domain (RBD) in the spike protein of MERS-CoV is a major target, and mouse, camel, or human-derived neutralizing mAbs targeting RBD have been developed. A major problem with neutralizing mAb therapy is mutant escape under selective pressure, which can be solved by combination of neutralizing mAbs targeting different epitopes. Neutralizing mAbs are currently under preclinical evaluation, and they are promising candidate therapeutic agents against MERS-CoV infection.<\/jats:p>","DOI":"10.3390\/v10120680","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T12:13:17Z","timestamp":1543579997000},"page":"680","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1923-5128","authenticated-orcid":false,"given":"Hui-Ju","family":"Han","sequence":"first","affiliation":[{"name":"School of Health Sciences, and State Key Laboratory of Virology, Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Health Sciences, and State Key Laboratory of Virology, Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[{"name":"Fudan University School of Medicine, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jie","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Health Sciences, and State Key Laboratory of Virology, Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1099\/jgv.0.000342","article-title":"Evidence for zoonotic origins of Middle East respiratory syndrome coronavirus","volume":"97","author":"Han","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1016\/S1473-3099(18)30127-0","article-title":"Middle East respiratory syndrome coronavirus: Risk factors and determinants of primary, household, and nosocomial transmission","volume":"18","author":"Hui","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijid.2015.07.014","article-title":"Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea","volume":"38","author":"Lee","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s11684-017-0596-6","article-title":"Human monoclonal antibodies as candidate therapeutics against emerging viruses","volume":"11","author":"Jin","year":"2017","journal-title":"Front. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00473-12","DOI":"10.1128\/mBio.00473-12","article-title":"Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans","volume":"3","author":"Lauber","year":"2012","journal-title":"mBio"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14728222.2017.1271415","article-title":"MERS-CoV spike protein: A key target for antivirals","volume":"21","author":"Du","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1128\/JVI.00433-14","article-title":"A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein","volume":"88","author":"Du","year":"2014","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virol.2016.01.004","article-title":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3\/2012","volume":"490","author":"Johnson","year":"2016","journal-title":"Virology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1128\/JVI.00912-14","article-title":"Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies","volume":"88","author":"Ying","year":"2014","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/infdis\/jiw080","article-title":"Prophylaxis with a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection","volume":"213","author":"Houser","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"31629","DOI":"10.1038\/srep31629","article-title":"Passive Transfer of a Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2017.03.025","article-title":"Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets","volume":"143","author":"Falzarano","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jiph.2016.04.003","article-title":"Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome","volume":"9","author":"Corti","year":"2016","journal-title":"J. Infect. Public Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2018.06.006","article-title":"Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets","volume":"156","author":"Feldmann","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/infdis\/jix209","article-title":"Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset","volume":"215","author":"Chen","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"234ra59","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.celrep.2018.06.041","article-title":"Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/infdis\/jiy311","article-title":"Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus from a Recovered Patient","volume":"218","author":"Niu","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s11427-018-9343-8","article-title":"A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice","volume":"61","author":"Niu","year":"2018","journal-title":"Sci. China Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally-Occurring Antibodies Devoid of Light-Chains","volume":"363","author":"Atarhouch","year":"1993","journal-title":"Nature"},{"key":"ref_29","first-page":"4586","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies","volume":"103","author":"Silence","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: Natural Single-Domain Antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08830185.2017.1397657","article-title":"Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections","volume":"37","author":"Wilken","year":"2018","journal-title":"Int. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2016.06.012","article-title":"Nanobodies(R) as inhaled biotherapeutics for lung diseases","volume":"169","author":"Allosery","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/AAC.01802-15","article-title":"Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection","volume":"60","author":"Detalle","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"eaas9667","DOI":"10.1126\/sciadv.aas9667","article-title":"Chimeric camel\/human heavy-chain antibodies protect against MERS-CoV infection","volume":"4","author":"Okba","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e00837-18","DOI":"10.1128\/JVI.00837-18","article-title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV","volume":"92","author":"Zhao","year":"2018","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Wang, L., Shi, W., Chappell, J.D., Joyce, M.G., Zhang, Y., Kanekiyo, M., Becker, M.M., van Doremalen, N., Fischer, R., and Wang, N. (2018). Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape. J. Virol.","DOI":"10.1128\/JVI.02002-17"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20290","DOI":"10.2807\/ese.17.40.20290-en","article-title":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012","volume":"17","author":"Bermingham","year":"2012","journal-title":"Eurosurveillance"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virol.2014.10.006","article-title":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry","volume":"471","author":"Song","year":"2014","journal-title":"Virology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1038\/emi.2017.50","article-title":"A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1099\/vir.0.060640-0","article-title":"Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus","volume":"95","author":"Coleman","year":"2014","journal-title":"J. Gen. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"De Wit, E., Prescott, J., Baseler, L., Bushmaker, T., Thomas, T., Lackemeyer, M.G., Martellaro, C., Milne-Price, S., Haddock, E., and Haagmans, B.L. (2013). The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069127"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/JVI.02935-13","article-title":"Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus","volume":"88","author":"Raj","year":"2014","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1128\/JVI.00661-15","article-title":"Asymptomatic Middle East Respiratory Syndrome Coronavirus Infection in Rabbits","volume":"89","author":"Haagmans","year":"2015","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1038\/s41598-018-28109-2","article-title":"Experimental infection of dromedaries with Middle East respiratory syndrome-Coronavirus is accompanied by massive ciliary loss and depletion of the cell surface receptor dipeptidyl peptidase 4","volume":"8","author":"Haverkamp","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/infdis\/jit590","article-title":"An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus","volume":"209","author":"Yao","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Falzarano, D., de Wit, E., Feldmann, F., Rasmussen, A.L., Okumura, A., Peng, X.X., Thomas, M.J., van Doremalen, N., Haddock, E., and Nagy, L. (2014). Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004250"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhao, G., Jiang, Y., Qiu, H., Gao, T., Zeng, Y., Guo, Y., Yu, H., Li, J., Kou, Z., and Du, L. (2015). Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145561"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/12\/680\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:33:34Z","timestamp":1760196814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/12\/680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["v10120680"],"URL":"https:\/\/doi.org\/10.3390\/v10120680","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}